Integrated Biosciences combines synthetic biology and machine learning to control cellular stress responses for next-generation therapeutics.
Investors 1
Funding Rounds 1
| Date | Series | Amount | Investors |
| 03.10.2024 | Seed | $17M | - |
Mentions in press and media 4
| Date | Title | Description |
| 03.10.2024 | Integrated Biosciences Raises $17M in Seed Funding | Integrated Biosciences, a Redwood City, CA-based synthetic biotechnology company developing therapeutics for age-related diseases, raised $17M in Seed funding.
The round was led by Sutter Hill Ventures with participation from Root Ventures,... |
| 21.12.2023 | Integrated Biosciences Unveils New Antibiotics Discovered With AI in Nature Publication | Publication validates the use of explainable deep learning in drug discovery and identifies a new class of antibiotics, one of the few in 60 years
Integrated Biosciences, a biotechnology company pioneering the use of synthetic biology and m... |
| - | Integrated Biosciences | “We use light to control biology and machine learning to harness chemistry.” |
| - | Integrated Biosciences | “Aging is an intrinsically complex systems biology challenge. Our Integrated Platform is purpose-built to unravel its intricate networks.” |
Reviews 0